CHECKING IN AT THE LEGISLATURE:
JULY 2025

Dear Friends and Neighbors,

As we honor the 175th anniversary of the pioneers entering the Salt Lake Valley, we celebrate their fortitude in the face of adversity, determination to live a land free from tyranny and persecution, and dedication to God, Family, and Country.  We honor the decades of building a territory and state supporting freedom of religion and thought, lawful and organized, and welcoming to people arriving from nations from around the world.

My family and I have very deep roots in Utah who have served our communities in various ways, and thank the many today and those who came before us who strive to protect a land of opportunity and freedom.  

May we never forget the sacrifices of those who have gone before and those who continue to build the great state of Utah.

QUICK LINKS

• You have the opportunity to help design our State Capitol!
• KSL—How the Days of '47 parade has changed over the years
• Current and prior editions of Interim Highlights can be found at le.utah.gov
• ABC4—Utah rated most independent of all the states
• UTA has a new route!
• KLS—UTA to implement 'significant' service changes. Here's what to know.

IN THIS ISSUE

Celebrating the first of its kind in an Utah Correctional facility, the Fit From Within running club brought inmates from all backgrounds and housing units for its first half marathon. I was thrilled to cheer them on and even see them take turns pushing an inmate in a wheelchair who recently completed chemotherapy. 

Click here for the full story! 

Levemir, the long-acting insulin most commonly approved for use during pregnancy, has been removed from the U.S. market. Alison Smart, president of the Alliance to Protect Insulin Choice and NSL resident, is working to bring a biosimilar version of this insulin to market.

Over the past year and a half, she has traveled frequently to Washington, D.C. to engage with Senate and Congressional offices. More recently, she has met twice with the Department of Health and Human Services as she works to secure continued access to this insulin, which was used by over one million people in the U.S. just a few years ago.